ABCC7 p.Gly314Glu

[switch to full view]
Comments [show]
Publications
PMID: 10021451 [PubMed] Zeitlin PL et al: "Novel pharmacologic therapies for cystic fibrosis."
No. Sentence Comment
128 Class IV mutants such as R117H, G314E, R334W, and R347P are associated with normal PKA-dependent phosphorylation and ATP binding.
X
ABCC7 p.Gly314Glu 10021451:128:32
status: NEW
Login to comment

PMID: 10578016 [PubMed] Smith SS et al: "Cystic fibrosis transmembrane conductance regulator. Physical basis for lyotropic anion selectivity patterns."
No. Sentence Comment
290 In the case of CFTR, it is possible to envision two sorts of CFTR pores: those that bind anions, exemplified by the wild-type channel, and those that do not, exemplified by mutant CFTRs like G314E or Q (Mansoura et al., 1998) and R347D (Tabcharani et al., 1993).
X
ABCC7 p.Gly314Glu 10578016:290:191
status: NEW
Login to comment

288 In the case of CFTR, it is possible to envision two sorts of CFTR pores: those that bind anions, exemplified by the wild-type channel, and those that do not, exemplified by mutant CFTRs like G314E or Q (Mansoura et al., 1998) and R347D (Tabcharani et al., 1993).
X
ABCC7 p.Gly314Glu 10578016:288:191
status: NEW
Login to comment

PMID: 10720936 [PubMed] Zeitlin PL et al: "Pharmacologic restoration of delta F508 CFTR-mediated chloride current."
No. Sentence Comment
101 CF nasal epithelia alone or in combination with isoproterenol demonstrated a modest hyperpolarization in the CLASS IV CONDUCTION MUTATIONS AREnasal potential difference response to low chloride in ASSOCIATED WITH A MILD PHENOTYPEnormal volunteers, but not in CF patients homozygous Class IV mutants such as R117H, G314E, R334 W, andfor ⌬F508.
X
ABCC7 p.Gly314Glu 10720936:101:314
status: NEW
Login to comment

PMID: 10940786 [PubMed] Zeitlin PL et al: "Future pharmacological treatment of cystic fibrosis."
No. Sentence Comment
22 Examples of CFTR mutations organized by classification of the defect in CFTR biosynthesis Type Genotype Phenotype Defect Cell diagram Drugs that may improve phenotype G542X 621+1 G → T 3905insT W1282X R553X 1717-1 G → A PI no CFTR protein no cell surface chloride transport gentamicin G418 Class II [64] 'F508 N1303K (P574H)a (A455E)a PI defective CFTR processing defective CFTR trafficking no cell surface chloride transport chemical chaperones CPX phenylbutyrate deoxyspergualin Class III [64] G551D G551S PI defective chloride channel regulation reduced or absent cell surface chloride transport genistein pyrophosphate Class IV [64, 66] R117H R334W G314E R347P ('F508)a P574H PS reduced chloride conductance reduced levels of cell surface chloride transport genistein milrinone phenylbutyrate Class V [64] 3849+10 kb C → T 2789+5 G → A 3272-26 A → G A455E 3120+1 G → A 1811+1.6 kb A → G 5Tb PS normal CFTR channels reduced numbers of normal CFTR reduced cell surface chloride transport genistein milrinone phenylbutyrate a Some mutants have features of more than one class of defect.
X
ABCC7 p.Gly314Glu 10940786:22:667
status: NEW
Login to comment

PMID: 11100963 [PubMed] Choo-Kang LR et al: "Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy."
No. Sentence Comment
106 These CFTR mutants including R117H, G314E, R334W, and R347P demonstrate a reduction in their chloride conductance or abnormal channel gating (see Fig. 2).
X
ABCC7 p.Gly314Glu 11100963:106:36
status: NEW
Login to comment

PMID: 11179391 [PubMed] Linsdell P et al: "Relationship between anion binding and anion permeability revealed by mutagenesis within the cystic fibrosis transmembrane conductance regulator chloride channel pore."
No. Sentence Comment
34 The hypothesis that anion permeability and anion binding are separable facets of the permeation process in the CFTR Cl¦ channel is supported by the fact that several mutations within the pore have been shown to alter anion binding without strongly affecting anion permeability (e.g. K335E, Anderson et al. 1991; R347D, Tabcharani et al. 1993; G314E, Mansoura et al. 1998).
X
ABCC7 p.Gly314Glu 11179391:34:348
status: NEW
Login to comment

200 Several mutations within the pore of CFTR alter permeant anion binding without strongly affecting anion selectivity (in terms of permeability ratios) (e.g. K335E, Anderson et al. 1991; G314E, Mansoura et al. 1998), suggesting that these mutations affect anion binding sites not intimately involved in the anion selectivity process (Smith et al. 1999; Linsdell et al. 2000).
X
ABCC7 p.Gly314Glu 11179391:200:185
status: NEW
Login to comment

PMID: 11741825 [PubMed] Zhang ZR et al: "Voltage-sensitive gating induced by a mutation in the fifth transmembrane domain of CFTR."
No. Sentence Comment
314 Other glutamate substitutions in TM domains 1, 5, 6, and 12 have been investigated [G91E, G314E, and K335E (16); S341E and T1134E (20)], but none of these exhibited voltage-dependent gating (McCarty and Dawson, unpublished observations).
X
ABCC7 p.Gly314Glu 11741825:314:90
status: NEW
Login to comment

PMID: 11966405 [PubMed] Sangiuolo F et al: "Towards the pharmacogenomics of cystic fibrosis."
No. Sentence Comment
114 R117H R334W G314E R347P ∆F508 P574H PS Reduced chloride conductance Reduced levels of cell surface chloride transport Genistein Milrinone Phenylbutyrate UTP INS36217 Moli1901 Class V Mutations causing defects in CFTR channel expression levels.
X
ABCC7 p.Gly314Glu 11966405:114:12
status: NEW
Login to comment

PMID: 15371908 [PubMed] Buyse IM et al: "Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: evidence that 3199del6 is a disease-causing mutation."
No. Sentence Comment
41 In the second case, an ASO result of a heterozygous G314E mutation was further characterized by MALDI-TOF mass spectrometry as a different allelic variant, G314A (data not shown).
X
ABCC7 p.Gly314Glu 15371908:41:52
status: NEW
Login to comment

77 This assay also demonstrated heterozygosity for the G542X mutation, and reflex testing for the 5T variant at CFTR intron 8 showed a genotype of 7T/9T in this patient (data not Table 3 Description of the 16 multiplex assays designed to analyze 51 CFTR mutations Multiplex Mutations Exon 1 1078delT, G314E, R352Q, G330X 7 2 R347H, R347P, R334W, 1717-1A 7, 11 3 R553X, S549N, R1162X 11, 19 4 A559T, R560T, G551D 11 5 G542X, S549R, 621ϩ1T, Y122X 4, 11 6 W1282X, 3876delA, 3905insT, D1152H 18, 20 7 3849ϩ4G, 3659delC, 1898ϩ1A 12, 19 8 405ϩ1A, 405ϩ3C, 3120A, 3120ϩ1A 3, 16 9 394delTT, E60X, G85E 3 10 A455E, ⌬F508a 9, 10 11 G480C, Q493X, V520F 10 12 711ϩ1T, G178R, 3199del6 5, 17a 13 2143delT, 2184delA, K710X, F316L 7, 13 14 I148T, R117H, R117C 4 15 N1303K, 2789ϩ5A, 3849ϩ10kbT 14b, intron19, 21 16 ⌬I507a 10 17 5Tb intron 8 a F508C and I507V, I506V, I506M variants are tested for concurrently with the ⌬F508 and ⌬I507 assays respectively.
X
ABCC7 p.Gly314Glu 15371908:77:298
status: NEW
Login to comment

93 Two previously unreported missense alleles were identified: G314A (allelic to G314E) and A455V (allelic to A455E).
X
ABCC7 p.Gly314Glu 15371908:93:78
status: NEW
Login to comment

PMID: 15880796 [PubMed] Kerem E et al: "Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy."
No. Sentence Comment
58 C-D565G II DF508 D1507 S549R S549I S549N S549R S945D S945L H1054D G1061R L1065P R1066C R1066M L1077P H1085R N1303K G85E III G551D S492F V520F R553G R560T R560S Y569D IV R117H, R117C, R117P, R117L D1152H, L88S, G91R, E92K, Q98R, P205S, L206W, L227R, F311L, G314E, R334W, R334Q, I336K, T338I, L346P, R347C, R347H, R347L, R347P, L927P, R1070W, R1070Q V 3849 þ 10 kb C !
X
ABCC7 p.Gly314Glu 15880796:58:256
status: NEW
Login to comment

PMID: 18178635 [PubMed] Stanke F et al: "Diversity of the basic defect of homozygous CFTR mutation genotypes in humans."
No. Sentence Comment
3 Results: CFTR activity in sweat gland, upper airways and distal intestine was normal for homozygous carriers of G314E or L997F and in the range of F508del homozygotes for homozygous carriers of E92K, W1098L, R553X, R1162X, CFTRdele2(ins186) or CFTRdele2,3(21 kb).
X
ABCC7 p.Gly314Glu 18178635:3:112
status: NEW
Login to comment

59 The missense mutation E92K results from a G-to-A transition in the first base of exon 4 and hence may not also lead to the substitution of a glutamate by a lysine but also may affect splicing as it has been observed for the stop mutation E92X.21 The G314E and the M1101K homozygotes exhibited an intermediate chloride secretory phenotype between typical CF and typical non-CF.
X
ABCC7 p.Gly314Glu 18178635:59:250
status: NEW
Login to comment

61 The transport rates were in the upper CF range (E92K, W1098L, one M1101K sibling), in the intermediate range between CF and non-CF (the other two M1101K siblings) or in the normal range (L997F, G314E) (fig 1C).
X
ABCC7 p.Gly314Glu 18178635:61:194
status: NEW
Login to comment

62 The tissue specimens from two M1101K homozygous siblings expressed two patterns of chloride secretory responses that are consistent with the presence of both CFTR and the alternative chloride channel ORCC (fig 1E, table 5).7 Since the outcome of NPD, ICM, sweat test and clinical examination was normal in the G314E or L997F homozygotes, the diagnosis of CF that had been based on mutation reports in the literature,18 19 positive family anamnesis or suggestive respiratory symptoms, was withdrawn for these two individuals.
X
ABCC7 p.Gly314Glu 18178635:62:310
status: NEW
Login to comment

70 Splice site mutations, for example, were associated with progressive lung disease and a Table 2 Assessment of basic defect (A): sweat tests and nasal potential difference (NPD) measurements (mV) Patient number CFTR genotype Sweat chloride concentration (mval/l) Basal PD (mV) Change in PD (mV) Day of assessment Prior tests (age) Amiloride Chloride-free + isoproterenol Out-of-frame deletion 1 CFTRdele2,3(21 kb)/CFTRdele2,3(21 kb) 103 95 (10 mo) 260 22 210 Nonsense mutation 2 R553X/R553X 96 100 (16 mo) 262 34 27 3 R1162X/R1162X 98 110 (2 y 1 mo) 248 23 24 4 R1162X/R1162X 104 112 (1 mo) 239 30 0 Splice-site mutation 5 1898+3 A-G/1898+3 A-G 73 69 (4 mo) 233 21 23 6 3849+10 kb C-T/3849+10 kb C-T 92 64 (20 y 5 mo) 244 30 212 49 (28 y 4 mo) 7 3849+10 kb C-T/3849+10 kb C-T 20 50 (11 y 2 mo) 227 12 +3 In-frame deletion 8 CFTRdele2(ins186)/CFTRdele2(ins186) 102 134 (4 mo) 245 30 21 9 CFTRdele2(ins186)/CFTRdele2(ins186) 100 119 (9 y) 248 31 28 10 CFTRdele2(ins186)/CFTRdele2(ins186) 131 100 (4 y) 258 41 212 Missense mutation 11 E92K/E92K 118 93 (8 mo) 252 20 211 12 G314E/G314E 15 43 (6 y 2 mo) 219 4 216 13 L997F/L997F 8 14 W1098L/W1098L 107 118 (2 mo) 15 M1101K/M1101K 108 120 256 33 216 16 M1101K/M1101K 130 120 264 26 215 17 M1101K/M1101K 118 229 13 210 F508del/F508del (n = 74)7 106¡22 256¡10 28¡9 28¡5 non-CF (n = 25) 16¡9 220¡10 11¡6 230¡8 Sibpairs: patients 3 & 4, 6 & 7, 9 & 10, 15, 16 & 17.
X
ABCC7 p.Gly314Glu 18178635:70:1069
status: NEW
X
ABCC7 p.Gly314Glu 18178635:70:1075
status: NEW
Login to comment

86 The non-conservative amino acid substitutions L997F and G314E did not impair chloride conductance in sweat glands, airways and intestine.
X
ABCC7 p.Gly314Glu 18178635:86:56
status: NEW
Login to comment

89 Several well characterised severe mutations occur in the evolutionarily conserved Walker (G1244E, G1249E) or dodecapeptide motifs (G551D, G1349D) of the ABC transporter CFTR.1 The missense mutants G622D23 in the regulatory domain and G314E in the fifth transmembrane region led to no clinical symptoms of CF.
X
ABCC7 p.Gly314Glu 18178635:89:234
status: NEW
Login to comment

97 ICM recordings of individuals homozygous for CFTRdele2,3(21 kb) (A), 1898+3 A-G (B), G314E (C), R1162X (D), M1101K (E) or of a healthy non-CF individual (F).
X
ABCC7 p.Gly314Glu 18178635:97:85
status: NEW
Login to comment

PMID: 20932301 [PubMed] Green DM et al: "Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients."
No. Sentence Comment
74 For Pa, the hazard ratio Table 1 Classification of CFTR alleles Category Mutation Specific mutations Class I Defective Protein Synthesis (nonsense, frameshift, aberrant splicing) 1078delT, 1154 insTC, 1525-2A > G, 1717-1G > A, 1898+1G > A, 2184delA, 2184 insA, 3007delG, 3120+1G > A, 3659delC, 3876delA, 3905insT, 394delTT, 4010del4, 4016insT, 4326delTC, 4374+1G > T, 441delA, 556delA, 621+1G > T, 621-1G > T, 711+1G > T, 875+1G > C, E1104X, E585X, E60X, E822X, G542X, G551D/R553X, Q493X, Q552X, Q814X, R1066C, R1162X, R553X, V520F, W1282X, Y1092X Class II Abnormal Processing and Trafficking A559T, D979A, ΔF508, ΔI507, G480C, G85E, N1303K, S549I, S549N, S549R Class III Defective Channel Regulation/Gating G1244E, G1349D, G551D, G551S, G85E, H199R, I1072T, I48T, L1077P, R560T, S1255P, S549 (R75Q) Class IV Decreased Channel Conductance A800G, D1152H, D1154G, D614G, delM1140, E822K, G314E, G576A, G622D, G85E, H620Q, I1139V, I1234V, L1335P, M1137V, P67L, R117C, R117P, R117H, R334W, R347H, R347P, R347P/ R347H, R792G, S1251N, V232D Class V Reduced Synthesis and/or Trafficking 2789+5G > A, 3120G > A, 3272-26A > G, 3849+10kbC > T, 5T variant, 621+3A > G, 711+3A > G, A445E, A455E, IVS8 poly T, P574H was increased 3 fold for those with 'Minimal` function when compared to those with 'Residual` function.
X
ABCC7 p.Gly314Glu 20932301:74:898
status: NEW
Login to comment

PMID: 9922376 [PubMed] Dawson DC et al: "CFTR: mechanism of anion conduction."
No. Sentence Comment
248 This effect is, in fact, seen in CFTR mutations (Fig. 3) is a function of the well depth, Gw 0 Gb , i.e. like G314E, which destabilizes relative anion binding, but also reduces single-channel conductance rather than increasing single-channel conductance as would be ex- bi Å expͫ0(Gw 0 Gb) RT ͬ (31) pected if only the well depth were affected (Mansoura and Dawson, unpublished data).
X
ABCC7 p.Gly314Glu 9922376:248:110
status: NEW
Login to comment

425 Iodide permeation ing must be interpreted with caution for a number of reasons. First, it has been demonstrated (101) that the In any survey of the permeation of monatomic and polyatomic anions through CFTR, iodide stands out asCFTR mutations (e.g., G314Q or G314E) result in CFTR channels that exhibit markedly reduced anion binding, exhibiting some unique, or perhaps exaggerated, properties.
X
ABCC7 p.Gly314Glu 9922376:425:259
status: NEW
Login to comment

597 Transmembrane segment 2 and TM6 sequences formed anion-selective channels in bilayers,the site of two patient mutations, and found that SCN block of CFTR was abolished in G314E and G314Q CFTR, whereas peptides based on TM1, TM3, TM4, and TM5 did not.
X
ABCC7 p.Gly314Glu 9922376:597:171
status: NEW
Login to comment

PMID: 19236881 [PubMed] Enquist K et al: "Membrane-integration characteristics of two ABC transporters, CFTR and P-glycoprotein."
No. Sentence Comment
113 For CFTR, we chose mutations located in TM1CFTR (F87L, G91R), TM3CFTR (P205S, L206W), TM4CFTR (C225R), TM5CFTR (DF311, G314E), TM6CFTR (R334L/W, I336K/R/D, I340N/S, L346P, R347L/H), TM8CFTR (S909I, S912L), TM9CFTR (I1005R, A1006E), TM10CFTR (Y1032N), and TM12CFTR (M1137R, ΔM1140, M1140K), or close to the TM region of TM1CFTR (R74W, L102R/P), TMF2CFTR (R117P/L, L137P), and TM11CFTR (M1101K/R).
X
ABCC7 p.Gly314Glu 19236881:113:119
status: NEW
Login to comment

109 For CFTR, we chose mutations located in TM1CFTR (F87L, G91R), TM3CFTR (P205S, L206W), TM4CFTR (C225R), TM5CFTR (DF311, G314E), TM6CFTR (R334L/W, I336K/R/D, I340N/S, L346P, R347L/H), TM8CFTR (S909I, S912L), TM9CFTR (I1005R, A1006E), TM10CFTR (Y1032N), and TM12CFTR (M1137R, ƊM1140, M1140K), or close to the TM region of TM1CFTR (R74W, L102R/P), TMF2CFTR (R117P/L, L137P), and TM11CFTR (M1101K/R).
X
ABCC7 p.Gly314Glu 19236881:109:119
status: NEW
Login to comment

PMID: 22698459 [PubMed] Lubamba B et al: "Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy."
No. Sentence Comment
982 Class Mutation prototypes Consequences Severe CF phenotype I G542X, W1282X, R553X, 3950delT CFTR is not synthesized because of stop codons or splicing defects II F508del, N1303K CFTR is synthesized but in an immature form (only partly glycosylated, misfolded, not released from the endoplasmic reticulum) and is mostly degraded by the ubiquitin-proteasomal pathway III G551D CFTR is synthesized and transported to the plasma membrane, but its activation and regulation by ATP or cAMP are disrupted Milder CF phenotype IV R334W, G314E, R347P, D1152H CFTR is synthesized and expressed at the plasma membrane, but chloride conductance is reduced V 3849+10 kb C>T, 3272-26 A>G CFTR synthesis or processing is partly defective Severe CF phenotype VI 1811+1.6 kb A>G CFTR is synthesized, but membrane stability or conductance of ions other than chloride is reduced Fig. 2.
X
ABCC7 p.Gly314Glu 22698459:982:528
status: NEW
Login to comment

PMID: 9674722 [PubMed] Schwiebert EM et al: "Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein."
No. Sentence Comment
243 Other mutations in TMD1 which affect function and cause disease include other arginines in predicted ␣-helix 6, R334W, R347P, and R347E (97,98) and a glycine, G314E, in ␣-helix 5 (99).
X
ABCC7 p.Gly314Glu 9674722:243:167
status: NEW
Login to comment

PMID: 9512029 [PubMed] Mansoura MK et al: "Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore."
No. Sentence Comment
28 Another residue in TM1, K95, was implicated as being important for anion selectivity (Anderson et al., 1991), but mutants at this locus did not give rise to robust expression in Xenopus oocytes. TM5 has a relatively high frequency of patient mutations compared with the other 11 putative TMs (Cystic Fibrosis Genetic Analysis Consortium, unpublished data), and two missense patient mutations, G314E (Golla et al., 1994) and G314R (Nasr et al., 1996), have been identified at G314.
X
ABCC7 p.Gly314Glu 9512029:28:393
status: NEW
Login to comment

62 Expression levels Wild-type and 11 mutant CFTR constructs were used in this study: G91A, G91E, G91R, G314A, G314D, G314E, G314Q, K335R, K335A, K335D, and K335E.
X
ABCC7 p.Gly314Glu 9512029:62:115
status: NEW
Login to comment

115 Most dramatic here was the substitution of glutamic acid (G314E), which raised conductance ratios for SCN, NO3, and Br.
X
ABCC7 p.Gly314Glu 9512029:115:58
status: NEW
Login to comment

116 It was of particular interest that the introduction of a glutamine (G314Q) also produced increased conductance ratios for the highly permeant anions and I, whereas the aspartic-acid-substituted construct (G314D) was not different from wtCFTR.
X
ABCC7 p.Gly314Glu 9512029:116:58
status: NEW
Login to comment

120 As an example, the I-V plots shown in Fig. 2, A and B, illustrate the effect of [SCN]o substitution on wild-type and G314E CFTR.
X
ABCC7 p.Gly314Glu 9512029:120:117
status: NEW
Login to comment

122 In the G314E mutant the attenuation of gCl by 2% [SCN]o was virtually abolished.
X
ABCC7 p.Gly314Glu 9512029:122:7
status: NEW
Login to comment

136 In the case of the G314E and G314Q mutants, however, the SCN effect appeared to be moderately voltage dependent (Fig. 2 TABLE 2 Summary of permeability and conductance ratios from anion substitution experiments n SCN NO3 Br HCOO I A.
X
ABCC7 p.Gly314Glu 9512029:136:19
status: NEW
Login to comment

137 Permeability Ratios Wild type 4-9 3.42 Ϯ 0.28 1.42 Ϯ 0.04 1.22 Ϯ 0.02 0.39 Ϯ 0.01 0.44 Ϯ 0.03 G91A 3-6 3.24 Ϯ 0.26 1.53 Ϯ 0.04 1.27 Ϯ 0.02 0.37 Ϯ 0.04 0.40 Ϯ 0.04 G91E 3-7 3.50 Ϯ 0.54 1.59 Ϯ 0.04 1.27 Ϯ 0.01 0.35 Ϯ 0.01 0.51 Ϯ 0.04 G91R 3-4 5.26 ؎ 0.46* 1.60 Ϯ 0.03 1.40 ؎ 0.01* 0.32 Ϯ 0.04 0.64 ؎ 0.04* G314A 3-4 2.87 Ϯ 0.17 1.45 Ϯ 0.03 1.19 Ϯ 0.02 0.31 Ϯ 0.03 0.33 Ϯ 0.03 G314D 4 3.42 Ϯ 0.34 1.44 Ϯ 0.05 1.25 Ϯ 0.04 0.33 Ϯ 0.03 0.51 Ϯ 0.05 G314E 3-4 3.72 Ϯ 0.56 1.65 ؎ 0.09* 1.35 ؎ 0.03* 0.49 Ϯ 0.04 0.53 Ϯ 0.04 G314Q 3-4 3.89 Ϯ 0.37 1.62 Ϯ 0.11 1.27 Ϯ 0.04 0.36 Ϯ 0.03 0.62 Ϯ 0.05 K335R 3-5 3.44 Ϯ 0.29 1.35 Ϯ 0.04 1.22 Ϯ 0.03 0.40 Ϯ 0.05 0.41 Ϯ 0.07 K335A 5-6 5.34 ؎ 0.58* 1.48 Ϯ 0.06 1.28 Ϯ 0.04 0.37 Ϯ 0.03 0.60 Ϯ 0.06 K335D 4-6 3.02 Ϯ 0.19 1.50 Ϯ 0.03 1.10 ؎ 0.02* 0.54 ؎ 0.04* 0.65 ؎ 0.06* K335E 5-8 3.64 Ϯ 0.21 1.48 Ϯ 0.06 1.29 Ϯ 0.03 0.46 Ϯ 0.04 1.10 ؎ 0.04* B. Conductance Ratios Wild type 4-9 0.14 Ϯ 0.02 0.75 Ϯ 0.02 0.64 Ϯ 0.02 0.52 Ϯ 0.03 0.18 Ϯ 0.03 G91A 3-6 0.14 Ϯ 0.01 0.77 Ϯ 0.02 0.61 Ϯ 0.02 0.47 Ϯ 0.02 0.19 Ϯ 0.02 G91E 3-7 0.15 Ϯ 0.03 0.73 Ϯ 0.02 0.60 Ϯ 0.01 0.50 Ϯ 0.04 0.30 Ϯ 0.02 G91R 3-4 0.14 Ϯ 0.00 0.84 Ϯ 0.01 0.63 Ϯ 0.01 0.32 ؎ 0.01* 0.14 Ϯ 0.01 G314A 3-4 0.30 Ϯ 0.09 0.89 ؎ 0.01* 0.66 Ϯ 0.01 0.48 Ϯ 0.09 0.24 Ϯ 0.01 G314D 4 0.28 Ϯ 0.05 0.82 Ϯ 0.01 0.70 Ϯ 0.02 0.49 Ϯ 0.06 0.27 Ϯ 0.03 G314E 3-4 0.62 ؎ 0.07* 1.18 ؎ 0.04* 0.84 ؎ 0.05* 0.42 Ϯ 0.05 0.29 Ϯ 0.09 G314Q 3-4 0.63 ؎ 0.02* 1.01 ؎ 0.04* 0.82 ؎ 0.03* 0.50 Ϯ 0.02 0.42 ؎ 0.02* K335R 3-5 0.14 Ϯ 0.01 0.76 Ϯ 0.03 0.61 Ϯ 0.02 0.59 Ϯ 0.06 0.16 Ϯ 0.03 K335A 6 0.20 Ϯ 0.03 0.77 Ϯ 0.02 0.61 Ϯ 0.02 0.45 Ϯ 0.03 0.21 Ϯ 0.02 K335D 4-6 0.65 ؎ 0.04* 1.25 ؎ 0.02* 0.89 ؎ 0.02* 0.61 Ϯ 0.06 0.58 ؎ 0.06* K335E 5-8 0.50 ؎ 0.06* 1.19 ؎ 0.03* 0.89 ؎ 0.02* 0.53 Ϯ 0.03 0.48 ؎ 0.03* (A) The apparent permeability ratios (PS/PCl) for each substitute anion were calculated from the shift in reversal potential using the Goldman-Hodgkin-Katz relation (noted in Materials and Methods).
X
ABCC7 p.Gly314Glu 9512029:137:19
status: NEW
X
ABCC7 p.Gly314Glu 9512029:137:622
status: NEW
X
ABCC7 p.Gly314Glu 9512029:137:1852
status: NEW
Login to comment

147 The data in Table 3 show that for wtCFTR and G314Q and G314E, two of the most severely affected constructs, PSCN/PCl calculated from the shift in Vr was independent of the fractional abundance of [SCN]o.
X
ABCC7 p.Gly314Glu 9512029:147:55
status: NEW
Login to comment

150 Of the three substitutions for G91, the arginine (G91R) altered the RR most dramatically, increasing it nearly sevenfold, although the negatively charged glutamate (G91E) FIGURE 2 The effect of replacement of [Cl- ]o by [SCN- ]o is shown for wtCFTR (A) and G314E (B).
X
ABCC7 p.Gly314Glu 9512029:150:257
status: NEW
Login to comment

169 TABLE 4 Quantitative analyses of the macroscopic I-V shape changes Mutant ⌬ Net charge n RR g(ϩ30)/g(-30) RR/RRWT Wild type 5 1.220 Ϯ 0.06 1.00 G91A 0 4 1.293 Ϯ 0.06 1.06 G91E -1 5 1.512 ؎ 0.10* 1.24 G91R 1 4 8.041 ؎ 0.87* 6.59 G314A 0 4 1.201 Ϯ 0.09 0.98 G314D -1 4 1.362 Ϯ 0.08 1.12 G314E -1 7 1.405 >e; 0.08 1.15 G314Q 0 5 1.376 Ϯ 0.10 1.13 K335R 0 4 1.209 Ϯ 0.06 0.99 K335A -1 4 1.295 Ϯ 0.07 1.06 K335D -2 5 0.762 ؎ 0.02* 0.62 K335E -2 4 0.919 ؎ 0.02* 0.75 The slope conductance was measured at ϩ30 mV and -30 mV with respect to the reversal potential.
X
ABCC7 p.Gly314Glu 9512029:169:334
status: NEW
X
ABCC7 p.Gly314Glu 9512029:169:351
status: NEW
Login to comment

171 TABLE 3 The permeability ratio (PSCN/PCl) is independent of the mole fraction of [SCN]0 for wtCFTR and the G314 variants [SCN]/{[SCN]ϩ[Cl]} n PSCN/PCl 0.02 0.05 0.10 0.20 0.50 0.90 Wild type 12 3.82 Ϯ 0.50 4.43 Ϯ 0.57 4.58 Ϯ 0.48 4.69 Ϯ 0.43 4.66 Ϯ 0.38 4.44 Ϯ 0.35 G314A 9 4.32 Ϯ 0.73 3.78 Ϯ 0.53 3.81 Ϯ 0.47 3.79 Ϯ 0.34 3.82 Ϯ 0.29 3.72 Ϯ 0.25 G314D 3 2.99 Ϯ 0.26 2.56 Ϯ 1.05 2.82 Ϯ 1.07 2.68 Ϯ 0.97 2.87 Ϯ 0.65 2.89 Ϯ 0.43 G314E 6 4.48 Ϯ 1.05 4.01 Ϯ 0.69 4.17 Ϯ 0.62 4.15 Ϯ 0.59 3.96 Ϯ 0.41 3.82 Ϯ 0.40 G314Q 3 5.39 Ϯ 0.57 4.49 Ϯ 0.58 4.69 Ϯ 1.26 4.05 Ϯ 1.26 3.86 Ϯ 1.47 3.68 Ϯ 1.51 The permeability ratios were calculated from the shift in reversal potential using the Goldman-Hodgkin-Katz equation.
X
ABCC7 p.Gly314Glu 9512029:171:540
status: NEW
Login to comment

173 TABLE 5 Concentration-dependent activation of wtCFTR, G91, G314, and K335 variants by IBMX in the presence of 10 ␮M forskolin Mutant n K1/2(IBMX) (mM) Wild type 15 0.35 Ϯ 0.04 G91A 5 0.42 Ϯ 0.06 G91E 8 0.51 ؎ 0.06* G91R 5 0.49 Ϯ 0.09 G314A 10 1.21 ؎ 0.11* G314D 3 1.35 ؎ 0.16* G314E 8 6.39 ؎ 1.35* G314Q 4 14.26 ؎ 6.64* K335R 4 0.46 Ϯ 0.04 K335A 2 0.35 Ϯ 0.15 K335D 7 0.87 ؎ 0.13* K335E 3 0.95 ؎ 0.07* The steady-state slope conductance was measured at -60 mV as increasing concentrations of IBMX (0.02-5.0 mM) were added to the perfusate in the continued presence of 10 mM forskolin.
X
ABCC7 p.Gly314Glu 9512029:173:319
status: NEW
Login to comment

175 Note that this fitting procedure allows us to estimate K1/2 values for even the most insensitive constructs, G314E and G314Q, despite the fact that these values were greater than the highest concentration of IBMX used in this study.
X
ABCC7 p.Gly314Glu 9512029:175:109
status: NEW
Login to comment

178 The K1/2 seen with either G314E or G314Q was comparable to that seen with nucleotide-binding mutations such as G551D that are associated with severe CF (Wilkinson et al., 1996).
X
ABCC7 p.Gly314Glu 9512029:178:26
status: NEW
Login to comment

195 The pattern of the effect of anion substitution was identical for Br, NO3, and SCN, and the conductance ratio for all three ions was increased in G314E and G314Q CFTR channels.
X
ABCC7 p.Gly314Glu 9512029:195:146
status: NEW
Login to comment

198 The results presented here are consistent with the notion that the binding of anions within the CFTR pore is a sensitive indicator of changes in pore structure whereas permeability ratios appear to be rather insensitive to similar TABLE 6 Qualitative summary of the functional consequences of mutations at G91, G314, and K335 Property G91 (TM1) K335 (TM6) G314 (TM5) G91A G91E G91R K335R K335A K335D K335E G314A G314D G314E G314Q I-V shape - - ϩϩϩ - - ϩϩ ϩ - - - - Psub/PCl - - - - - - ϩϩ - - - - gsub/gCl - - - - - ϩϩϩ ϩϩϩ ϩϩ - ϩϩϩ ϩϩϩ SCN- binding - - - - - ϩϩϩ ϩϩϩ ϩϩ - ϩϩϩϩ ϩϩϩϩ Activation - - - - - ϩϩ ϩϩ ϩϩϩ ϩϩϩ ϩϩϩϩ ϩϩϩϩ Results are expressed as follows: -, function of the CFTR construct with the indicated substitution was indistinguishable from wild type; ϩ to ϩϩϩϩ, semiquantitative indication of the magnitude of the change in the function compared with wild type.
X
ABCC7 p.Gly314Glu 9512029:198:418
status: NEW
Login to comment

233 The increased conductance ratios seen in G314E, G314Q, and to a lesser extent, G314A channels are compatible with the hypothesis that substitution for G314 distorted an anion binding site such that the affinities for Br, NO3, and SCN were all reduced relative to Cl.
X
ABCC7 p.Gly314Glu 9512029:233:41
status: NEW
Login to comment

263 In contrast, G314E CFTR exhibited a dramatic decrease in anion binding and sensitivity to activation by IBMX but no change in I-V shape.
X
ABCC7 p.Gly314Glu 9512029:263:13
status: NEW
Login to comment

121 As an example, the I-V plots shown in Fig. 2, A and B, illustrate the effect of [SCN]o substitution on wild-type and G314E CFTR.
X
ABCC7 p.Gly314Glu 9512029:121:117
status: NEW
Login to comment

123 In the G314E mutant the attenuation of gCl by 2% [SCN]o was virtually abolished.
X
ABCC7 p.Gly314Glu 9512029:123:7
status: NEW
Login to comment

138 Permeability Ratios Wild type 4-9 3.42 afe; 0.28 1.42 afe; 0.04 1.22 afe; 0.02 0.39 afe; 0.01 0.44 afe; 0.03 G91A 3-6 3.24 afe; 0.26 1.53 afe; 0.04 1.27 afe; 0.02 0.37 afe; 0.04 0.40 afe; 0.04 G91E 3-7 3.50 afe; 0.54 1.59 afe; 0.04 1.27 afe; 0.01 0.35 afe; 0.01 0.51 afe; 0.04 G91R 3-4 5.26 d1e; 0.46* 1.60 afe; 0.03 1.40 d1e; 0.01* 0.32 afe; 0.04 0.64 d1e; 0.04* G314A 3-4 2.87 afe; 0.17 1.45 afe; 0.03 1.19 afe; 0.02 0.31 afe; 0.03 0.33 afe; 0.03 G314D 4 3.42 afe; 0.34 1.44 afe; 0.05 1.25 afe; 0.04 0.33 afe; 0.03 0.51 afe; 0.05 G314E 3-4 3.72 afe; 0.56 1.65 d1e; 0.09* 1.35 d1e; 0.03* 0.49 afe; 0.04 0.53 afe; 0.04 G314Q 3-4 3.89 afe; 0.37 1.62 afe; 0.11 1.27 afe; 0.04 0.36 afe; 0.03 0.62 afe; 0.05 K335R 3-5 3.44 afe; 0.29 1.35 afe; 0.04 1.22 afe; 0.03 0.40 afe; 0.05 0.41 afe; 0.07 K335A 5-6 5.34 d1e; 0.58* 1.48 afe; 0.06 1.28 afe; 0.04 0.37 afe; 0.03 0.60 afe; 0.06 K335D 4-6 3.02 afe; 0.19 1.50 afe; 0.03 1.10 d1e; 0.02* 0.54 d1e; 0.04* 0.65 d1e; 0.06* K335E 5-8 3.64 afe; 0.21 1.48 afe; 0.06 1.29 afe; 0.03 0.46 afe; 0.04 1.10 d1e; 0.04* B. Conductance Ratios Wild type 4-9 0.14 afe; 0.02 0.75 afe; 0.02 0.64 afe; 0.02 0.52 afe; 0.03 0.18 afe; 0.03 G91A 3-6 0.14 afe; 0.01 0.77 afe; 0.02 0.61 afe; 0.02 0.47 afe; 0.02 0.19 afe; 0.02 G91E 3-7 0.15 afe; 0.03 0.73 afe; 0.02 0.60 afe; 0.01 0.50 afe; 0.04 0.30 afe; 0.02 G91R 3-4 0.14 afe; 0.00 0.84 afe; 0.01 0.63 afe; 0.01 0.32 d1e; 0.01* 0.14 afe; 0.01 G314A 3-4 0.30 afe; 0.09 0.89 d1e; 0.01* 0.66 afe; 0.01 0.48 afe; 0.09 0.24 afe; 0.01 G314D 4 0.28 afe; 0.05 0.82 afe; 0.01 0.70 afe; 0.02 0.49 afe; 0.06 0.27 afe; 0.03 G314E 3-4 0.62 d1e; 0.07* 1.18 d1e; 0.04* 0.84 d1e; 0.05* 0.42 afe; 0.05 0.29 afe; 0.09 G314Q 3-4 0.63 d1e; 0.02* 1.01 d1e; 0.04* 0.82 d1e; 0.03* 0.50 afe; 0.02 0.42 d1e; 0.02* K335R 3-5 0.14 afe; 0.01 0.76 afe; 0.03 0.61 afe; 0.02 0.59 afe; 0.06 0.16 afe; 0.03 K335A 6 0.20 afe; 0.03 0.77 afe; 0.02 0.61 afe; 0.02 0.45 afe; 0.03 0.21 afe; 0.02 K335D 4-6 0.65 d1e; 0.04* 1.25 d1e; 0.02* 0.89 d1e; 0.02* 0.61 afe; 0.06 0.58 d1e; 0.06* K335E 5-8 0.50 d1e; 0.06* 1.19 d1e; 0.03* 0.89 d1e; 0.02* 0.53 afe; 0.03 0.48 d1e; 0.03* (A) The apparent permeability ratios (PS/PCl) for each substitute anion were calculated from the shift in reversal potential using the Goldman-Hodgkin-Katz relation (noted in Materials and Methods).
X
ABCC7 p.Gly314Glu 9512029:138:622
status: NEW
X
ABCC7 p.Gly314Glu 9512029:138:1852
status: NEW
Login to comment

148 The data in Table 3 show that for wtCFTR and G314Q and G314E, two of the most severely affected constructs, PSCN/PCl calculated from the shift in Vr was independent of the fractional abundance of [SCN]o.
X
ABCC7 p.Gly314Glu 9512029:148:55
status: NEW
Login to comment

151 Of the three substitutions for G91, the arginine (G91R) altered the RR most dramatically, increasing it nearly sevenfold, although the negatively charged glutamate (G91E) FIGURE 2 The effect of replacement of [Clafa; ]o by [SCNafa; ]o is shown for wtCFTR (A) and G314E (B).
X
ABCC7 p.Gly314Glu 9512029:151:269
status: NEW
Login to comment

PMID: 8829633 [PubMed] Nasr SZ et al: "Novel missense mutation (G314R) in a cystic fibrosis patient with hepatic failure."
No. Sentence Comment
56 CFTR constructs bearing either the G314A or G314E substitution were associated with readily discernable CAMP-induced C1 currents.
X
ABCC7 p.Gly314Glu 8829633:56:44
status: NEW
Login to comment

57 The G314E substitution has been associated with cystic fibrosis (GollaL et al., 1994).
X
ABCC7 p.Gly314Glu 8829633:57:4
status: NEW
Login to comment

73 Cyclic AMP-activated C1 currents were only barely detectable with this construct, whereas wt and AF508 CFTR, as well as variants bearing more conservative substitutions at the same site (G314A and G314E), were associated with the expression of significant C1 channel function.
X
ABCC7 p.Gly314Glu 8829633:73:197
status: NEW
Login to comment

PMID: 8825494 [PubMed] Zielenski J et al: "Cystic fibrosis: genotypic and phenotypic variations."
No. Sentence Comment
634 Examples of this group include R l 17H near TM2, G314E in TM5, and R334W and R347P in TM6.
X
ABCC7 p.Gly314Glu 8825494:634:49
status: NEW
Login to comment

PMID: 7509564 [PubMed] Grebe TA et al: "Genetic analysis of Hispanic individuals with cystic fibrosis."
No. Sentence Comment
45 The following CFTR gene mutations were identified by published methods: AF508 (Rommens et al. 1990); G542X (Kerem et al. 1990); GS51D and R553X (Cutting et al. 1990); R1162X (Gasparini et al. 1991); W1282X (Vidaud et al. 1990); N1303K (Osborne et al. 1991); 3849 +lOkbC- T (Highsmith et al., submitted); and R117H, Y122X, 1148T, 621+1G-*oT, 711+1G- T, G314E, 1078AT, R334W, R347P, Q493X, A1507, V520F, 1717 -1G-oA, R560T, and 3569AC (J. DeMarchi et al., submitted).
X
ABCC7 p.Gly314Glu 7509564:45:352
status: NEW
Login to comment

54 COther = A1507, 621+1G- T, R117H, N1303K, 711+1G-*.T, 1717-1G-.A, R560T, Y122X, 1148T, G314E, 1078AT, R347P, Q493X, V520F, and 3659AC.
X
ABCC7 p.Gly314Glu 7509564:54:87
status: NEW
Login to comment

56 The G542X mutation was found in 5.4% of Hispanic CF chromosomes, similar to the 3% frequency in the general population.
X
ABCC7 p.Gly314Glu 7509564:56:86
status: NEW
Login to comment

47 The following CFTR gene mutations were identified by published methods: AF508 (Rommens et al. 1990); G542X (Kerem et al. 1990); GS51D and R553X (Cutting et al. 1990); R1162X (Gasparini et al. 1991); W1282X (Vidaud et al. 1990); N1303K (Osborne et al. 1991); 3849 +lOkbC-T (Highsmith et al., submitted); and R117H, Y122X, 1148T, 621+1G-*oT, 711+1G-T, G314E, 1078AT, R334W, R347P, Q493X, A1507, V520F, 1717 -1G-oA, R560T, and 3569AC (J. DeMarchi et al., submitted).
X
ABCC7 p.Gly314Glu 7509564:47:350
status: NEW
Login to comment

PMID: 12531063 [PubMed] Lim M et al: "Therapeutic strategies to correct malfunction of CFTR."
No. Sentence Comment
60 Type Genotype Phenotypea Defect Potential therapeutics Class I G542X PI No CFTR synthesis, aminoglycosides 621 + 1 G ࢐T No cell surface Cl- 3905insT transport W1282X R553X 1717-1 G ࢐ A Class II F508b PI Defective CFTR 4-PBA, flavonoids, N1303K trafficking and chemical chaperones, P574Hb processing xanthines A455Eb Class III G551D PI Defective channel flavonoids, milrinone G551S regulation, reduced or absent Cl-transport Class IV R117H PS Reduced Cl-transport 4-PBA, xanthines, R334W flavonoids G314E R347P F508b P574Hb ClassV 3849 + 10 kb C࢐T PS Reduced number of flavonoids, milrinone, 2789 + 5 G ࢐A normal CFTR proteins 4-PBA 3272 - 26 A ࢐ G Reduced Cl-transport A455Eb 3120+1 G࢐A 1811 + 1.6 kb A ࢐ G a PI indicates pancreatic insufficiency; PS indicates pancreatic sufficiency.
X
ABCC7 p.Gly314Glu 12531063:60:510
status: NEW
Login to comment

PMID: 24517344 [PubMed] Raju SV et al: "Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis."
No. Sentence Comment
81 As expected based on genotype-phenotype correlations in the disease [33], HBE cells derived from a F508del CFTR heterozygote had slightly lower CFTR activity at baseline than wild type monolayers as measured by Table 1 List of CFTR mutations analyzed F508del R117H 1717-1G > A R117C G85E R334W 1898 + 1G > A Y122X A455E R347P 2184delA G178R I507del R553X 2789 + 5G > A G314E G542X R560T 3120 + 1G > A G330X G551D W1282X 3659delC R347H N1303K 621 + 1G > T K710X 406-1G > A R1162X 711 + 1G > T E60X G480C R1066C W1089X V520F A559T S1196X Q1238X S1251N S1255X 663delT 935delA 1161delC 1288insTA 2184insA 2307insA 2711delT 2869insG R709X R764X R1158X 574delA Q493X 1898 + 5G > T 3905insT I506T 3849 + 10kbC > T 712-1G > T Q98R Q552X S549N 1078delT H199Y 444delA S549R (T > G) 2143delT P205S 2043delG 1811 + 1.6kbA > G 3272-26A > G L206W 3791delC Y1092X (C > G) 3199del6 F508C 2108delA Y1092X (C > A) D1152H V520I 3667del4 394delTT 3876delA M1101K 1677delTA W1098X (TGA) 1812-1G > A 4016insT 1609delCA 3171delC response to forskolin stimulation (49.3 &#b1; 11.5 bc;A/cm2 in CFTR (+/+) vs. 40.5 &#b1; 5.3 bc;A/cm2 in CFTR (+/-), although this was not statistically significant (Figure 1A,B).
X
ABCC7 p.Gly314Glu 24517344:81:369
status: NEW
Login to comment